Fidson Healthcare Plc (NGX:FIDSON)
Nigeria · Delayed Price · Currency is NGN | Market Cap | 242.88B +280.0% |
| Revenue (ttm) | 126.65B +26.2% |
| Net Income | 11.19B +69.3% |
| EPS | 4.61 +59.8% |
| Shares Out | 2.40B |
| PE Ratio | 21.95 |
| Forward PE | 17.91 |
| Dividend | 1.50 (1.48%) |
| Ex-Dividend Date | Apr 15, 2026 |
| Volume | 632,224 |
| Open | n/a |
| Previous Close | 101.20 |
| Day's Range | n/a |
| 52-Week Range | 37.80 - 136.50 |
| Beta | 0.71 |
| Analysts | Hold |
| Price Target | 100.40 (-0.79%) |
| Earnings Date | Jul 28, 2026 |
About Fidson Healthcare
Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria. The company operates in three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, capsules, syrups, tablets, and injectables. The company also provides products for anti-infective and anti-malaria, central nervous system, and cough and cold, gastrointestinal medicines; supplements; topical/dermatological medicines; vitamins and minerals; and ophthalmic solutions. Fidson Healthcare Plc was incorporated in ... [Read more]
Financial Performance
In 2025, Fidson Healthcare's revenue was 119.06 billion, an increase of 41.42% compared to the previous year's 84.19 billion. Earnings were 9.88 billion, an increase of 124.68%.
Financial StatementsNews
Haleon introduces new corporate identity in Nigeria, partners with Fidson
Haleon’s collaboration with Fidson Healthcare forms part of this approach, reinforcing the value of local production in supporting trusted everyday health brands in Nigeria. The post Haleon introduces...